Balázs Szigeti

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 6

Top Topics

Major Depressive Disorder

Drug Administration

Top Venues

Psychological medicine

British journal of clinical pharmacology

Journal of psychopharmacology (Oxford, England)

University of Edinburgh (PHD)

This page only lists publications with an associated author ORCID identifier.

Education History

University of Edinburgh Sep 01 2013 - May 01 2017

United Kingdom

PHD :: School of Informatics

Imperial College London Sep 01 2011 - May 31 2012

United Kingdom

MSC :: Physics

Imperial College London Sep 01 2007 - May 31 2011

United Kingdom

BSC :: Physics

Publications

Balázs Szigeti, Brandon Weiss, Fernando E Rosas, David Erritzoe, David Nutt, Robin Carhart-Harris
Assessing expectancy and suggestibility in a trial of escitalopram v. psilocybin for depression. Psychological medicine (2024)
Balázs Szigeti, Brandon Weiss, Fernando E Rosas, David Erritzoe, David Nutt, Robin Carhart-Harris
Assessing expectancy and suggestibility in a trial of escitalopram v. psilocybin for depression. Psychological medicine 54 (8) (2024)
Balázs Szigeti, Brandon Weiss, Fernando E Rosas, David Erritzoe, David Nutt, Robin Carhart-Harris
Assessing expectancy and suggestibility in a trial of escitalopram v. psilocybin for depression. Psychological medicine 54 (8) (2024)
Balázs Szigeti, Lawrence D Phillips, David John Nutt
Bayesian analysis of real-world data as evidence for drug approval: Remembering Sir Michael Rawlins. British journal of clinical pharmacology (2023)
Balázs Szigeti, Laura Kartner, Allan Blemings, Fernando E Rosas, Amanda Feilding, David John Nutt, Robin L Carhart-Harris, David Erritzoe
Self-blinding citizen science to explore psychedelic microdosing. eLife 10 (2021)
Balázs Szigeti, Adam R Winstock, David Erritzoe, Larissa J Maier
Are ecstasy induced serotonergic alterations overestimated for the majority of users? Journal of psychopharmacology (Oxford, England) 32 (7) (2018)